Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners

Sponsor
Future University in Egypt (Other)
Overall Status
Completed
CT.gov ID
NCT04747743
Collaborator
Ain Shams University (Other), British University In Egypt (Other), Cairo University (Other)
170
1
1.1
156.8

Study Details

Study Description

Brief Summary

Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system

Condition or Disease Intervention/Treatment Phase
  • Other: a self structured questionnaire

Detailed Description

Skeletal muscle relaxants (SMR) are a diverse group of medications that are not chemically related like other drug classes and work through a variety of mechanisms. The term "muscle relaxant" is used to refer to two major therapeutic groups: neuromuscular blockers and spasmolytic. Some of them are working mainly through the central nervous system; they have many adverse effects such as sedation and dizziness that may limit their use.

Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system

Study Design

Study Type:
Observational
Actual Enrollment :
170 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of Dentist Pharmacist Communication About Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners
Actual Study Start Date :
Feb 10, 2021
Actual Primary Completion Date :
Mar 10, 2021
Actual Study Completion Date :
Mar 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Egyptian dental practitioners

170 dental practitioners in Egypt (professionals both academic and nonacademic).

Other: a self structured questionnaire
A self structured questionnaire to assess knowledge of skeletal muscle use in dental practice

Outcome Measures

Primary Outcome Measures

  1. Dental practitioner's knowledge about muscle relaxants indications [1 month]

    Extent of dental practitioner's knowledge about muscle relaxants indications in practice

  2. importance of direct communication between dental practitioners and pharmacists in order to detect the communication barriers and how to overcome those barriers. [1 month]

    To assess and improve the communication between pharmacist- dentist regarding Skeletal muscle relaxant

Secondary Outcome Measures

  1. Dental practitioner's knowledge about muscle relaxants doses [1 month]

    Extent of dental practitioner's knowledge about muscle relaxants different doses in practice

  2. Dental practitioner's knowledge about muscle relaxants side effects [1 month]

    Extent of dental practitioner's knowledge about muscle relaxants possible side effects

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • academic dental practitioners in Egypt

  • nonacademic dental practitioners in Egypt

Exclusion Criteria:
  • Age less than 20 or more than 60

  • Non-dental

Contacts and Locations

Locations

Site City State Country Postal Code
1 Future University in egypt Cairo Egypt

Sponsors and Collaborators

  • Future University in Egypt
  • Ain Shams University
  • British University In Egypt
  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Doaa Mohamed Salah ElDin Diab ELBohy, Associate professor, Future University in Egypt
ClinicalTrials.gov Identifier:
NCT04747743
Other Study ID Numbers:
  • FUE.REC 1/1-2021
First Posted:
Feb 10, 2021
Last Update Posted:
May 27, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 27, 2022